Company News for April 27, 2011 - Corporate Summary

•    Hospira

reported Q1 EPS of $0.93, well ahead of the Zacks Consensus Estimate of $0.78 per share. Revenues for the quarter fell less by than a percent to $1.0 billion, topping the Zacks Consensus Estimate of $941.0 million

•    Ford

reported Q1 EPS of $0.61, beating the Zacks Consensus Estimate of $0.50 per share. Revenues for the quarter rose 17.8% year-over-year to $33.1 billion, higher than the Zacks Consensus Estimate of $30.188 billion

•    Lockheed Martin Corp

reported Q1 EPS of $1.55, above the Zacks Consensus Estimate for $1.51 per share. Revenues for the quarter increased 2.9% year-over-year to $10.63 billion, slightly lower than the Zacks Consensus Estimate of $10.644 billion

•    Bearings and specialty steel manufacturer The Timken Co.

raised its full year 2011 EPS guidance to between $3.80 and $4.10, from prior guidance of $3.30 to $3.60

•    Share prices of biotechnology firm Endocyte, Inc.'s

rose 32.18% after the company said it was requesting European Union approval to market its treatment for ovarian cancer

•    Morgan Joseph analysts upgraded shares of Central European Media Enterprises Ltd.

from “Hold” to "Buy” rating with a target price of $25.00

•    Bank of America Merrill Lynch upgraded Ingersoll-Rand

to "Buy" from “Neutral” rating with a price target  of $61.00 per share on the stock

•    Analysts at Piper Jaffrey upgraded Johnson Controls, Inc.

to "Overweight" from “Neutral” rating with a price target of $47.00 per share up from $46.00

•    Analysts at JPMorgan Chase & Co. upgraded Mission West Properties, Inc.

to "Neutral" from an “Underweight” rating with a target price of $7.00 raised from $6.00

•    C.H. Robinson Worldwide

reported Q1 EPS of $0.59, slightly lower than the Zacks Consensus Estimate of $0.60 per share. Revenues for the quarter rose 14% year-over-year to $2.36 billion, ahead of the Zacks Consensus Estimate of $2.293 billion

•    Becton Dickinson

reported Q1 EPS of $1.38, ahead of the Zacks Consensus Estimate of $1.30 per share. Revenues for the quarter rose 7% year-over-year to $1.92 billion, above the Zacks Consensus Estimate of $1.856 billion